Aulos Bioscience

Aulos Bioscience is a pioneering brand in the field of immuno-oncology, dedicated to revolutionizing cancer patient care. With their groundbreaking IL-2 therapeutic, AU-007, they have achieved a notable changemaker status. Unlike other IL-2 therapeutics, AU-007 offers a novel approach that addresses the pressing need to eliminate cancer.

By unlocking the anti-cancer power of interleukin-2, Aulos Bioscience is dismantling barriers in immuno-oncology with a unique immunotherapy that has been computationally designed to precisely direct the body's immune system towards killing tumor cells. This innovative brand's approach is grounded in Biolojic Design's state-of-the-art artificial intelligence antibody design platform, which employs machine learning algorithms to meticulously create functional human monoclonal antibodies for novel therapeutic activities. Aulos Bioscience is dedicated to providing significantly improved treatment options to patients suffering from solid tumor cancers.

Their lead antibody, AU-007, offers a simple yet elegant solution for harnessing the immunotherapeutic power of IL-2. To learn more about Aulos Bioscience and their transformative work, visit their website